Literature DB >> 6538936

Characterization of forskolin binding sites in rat brain membranes using [14,15-3H]14,15-dihydroforskolin as a ligand.

K Schmidt, R Munshi, H P Baer.   

Abstract

[14,15-3H]14,15-Dihydroforskolin [( 3H]DHF) has been used as a radioactive ligand to identify forskolin binding sites in rat brain membranes. The binding was saturable and reversible. The binding sites showed positive cooperative properties as evident from an upward convex Scatchard plot and a Hill coefficient of 1.6. The equilibrium dissociation constants (KD) were in the range between 10 microM and 10 nM as estimated from the limiting slopes of the curved Scatchard plot. Half-maximal saturation of the binding sites was observed at a ligand concentration of 225 nM. The binding kinetics were very rapid: Binding equilibrium was reached in less than 2 min and a large excess of cold forskolin displaced 80% of the radioligand within 2 min. The dissociation reaction was not first order, characterized by a decreasing dissociation rate constant. Bound [3H]DHF could be displaced with forskolin (IC50 0.3 microM), 14,15-dihydroforskolin (IC50 0.8 microM) and 7-desacetylforskolin (IC50 3 microM). However, nucleotides (ATP, GTP) and other receptor ligands (adenosine, isoproterenol) had no effect on the binding. Although the density of the forskolin binding sites (3.2 pmole/mg protein) is similar to those of other adenylate cyclase linked receptors, discrepancies between the KD and the ED50 obtained in adenylate cyclase studies and the finding that activation of the enzyme by forskolin is negative cooperative makes it difficult to clearly relate the binding sites to adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6538936     DOI: 10.1007/bf00506195

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  23 in total

1.  Insulin interactions with liver plasma membranes. Independence of binding of the hormone and its degradation.

Authors:  P Freychet; R Kahn; J Roth; D M Neville
Journal:  J Biol Chem       Date:  1972-06-25       Impact factor: 5.157

2.  Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine.

Authors:  U Schwabe; T Trost
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

3.  Differences in the forskolin activation of adenylate cyclases in wild-type and variant lymphoma cells.

Authors:  R B Clark; T J Goka; D A Green; R Barber; R W Butcher
Journal:  Mol Pharmacol       Date:  1982-11       Impact factor: 4.436

4.  The positive inotropic-acting forskolin, a potent adenylate cyclase activator.

Authors:  H Metzger; E Lindner
Journal:  Arzneimittelforschung       Date:  1981

5.  Positive inotropic and blood pressure lowering activity of a diterpene derivative isolated from Coleus forskohli: Forskolin.

Authors:  E Lindner; A N Dohadwalla; B K Bhattacharya
Journal:  Arzneimittelforschung       Date:  1978

6.  Structure-activity relationships for activation of adenylate cyclase by the diterpene forskolin and its derivatives.

Authors:  K B Seamon; J W Daly; H Metzger; N J de Souza; J Reden
Journal:  J Med Chem       Date:  1983-03       Impact factor: 7.446

7.  Forskolin binding sites in rat liver and brain membranes.

Authors:  K Schmidt; H P Baer
Journal:  Eur J Pharmacol       Date:  1983-10-28       Impact factor: 4.432

Review 8.  Forskolin: a unique diterpene activator of cyclic AMP-generating systems.

Authors:  K B Seamon; J W Daly
Journal:  J Cyclic Nucleotide Res       Date:  1981

9.  Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein.

Authors:  K Seamon; J W Daly
Journal:  J Biol Chem       Date:  1981-10-10       Impact factor: 5.157

10.  Forskolin requires more than the catalytic unit to activate adenylate cyclase.

Authors:  D Stengel; L Guenet; M Desmier; P Insel; J Hanoune
Journal:  Mol Cell Endocrinol       Date:  1982 Nov-Dec       Impact factor: 4.102

View more
  1 in total

1.  Bronchodilator-mediated relaxation of normal and ovalbumin-sensitized guinea-pig airways: lack of correlation with lung adenylate cyclase activation.

Authors:  J F Burka; M H Saad
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.